Our Press Releases | Association for Accessible Medicines

AAM All Access Podcast - Featuring AAM CEO Dan Leonard and leaders in the generics and biosimilars industry.

Teamwork of business colleagues, consultation new strategy plan business and market growth on financial document graph report, conference to making growth profit

Jul 28, 2021 | Rachel Schwartz

Joanne Duncan Joins AAM as Chief Operating Officer

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors

Jul 19, 2021 | Rachel Schwartz

AAM Releases New Report: New Generics Are Less Available in Medicare Than Commercial Plans

New NAFTA - North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Jul 1, 2021 | Rachel Schwartz

AAM Statement on the Anniversary of USMCA

The Maine State House in Augusta, Maine.

Jun 30, 2021 | Rachel Schwartz

AAM Statement on Gov. Mills’ Veto of LD 1117

The Maine State Capitol building in Augusta

Jun 18, 2021 | Rachel Schwartz

AAM Statement on Governor Mill’s Consideration of LD 1117

United States Supreme Court in Washington DC. with Statue of the Guardian or Authority of Law.

Jun 17, 2021 | Rachel Schwartz

AAM and Biosimilars Council Statement on ACA Ruling in California v. Texas

The Maine State Capitol building in Augusta

Jun 16, 2021 | Rachel Schwartz

AAM Statement on Maine LD 1117

The back lawn of the White House with its trees and fountain

Jun 8, 2021 | Rachel Schwartz

AAM Statement on Biden-Harris Administration’s 100-Day Supply Chain Review

Black Women’s Health Imperative (BWHI)

May 26, 2021 | Rachel Schwartz

Black Women’s Health Imperative Named AAM’s 2021 “Champion of Access”

AAM board room

May 24, 2021 | Erica Klinger

AAM Names Erik Komendant Senior Vice President, Government Affairs

Close up shot of vaccines and syringe in a laboratory

May 24, 2021 | Rachel Schwartz

Steven Selde Joins AAM’s Biosimilars Council as Director

May 17, 2021 | Rachel Schwartz

Monét Stanford Joins AAM as Director, Policy